ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Effectiveness of a Normalization of Eating Intervention Program for Treating Women With Eating Disorders

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Effectiveness of a Normalization of Eating Intervention Program for Treating Women With Eating Disorders
Official Title  Adaptation of a CBT Intervention for Eating Disorders
Brief Summary

This study will evaluate the effectiveness of a new approach to a normalization of eating program, based on principles of cognitive-behavioral therapy, in treating women with anorexia nervosa or bulimia nervosa.

Detailed Description

Eating disorders are real, treatable medical illnesses. They are often characterized by disturbances in eating behavior, such as drastic reduction of food intake or extreme overeating, as well as feelings of distress or extreme concern about body shape or weight. The two main types of eating disorders are anorexia nervosa and bulimia nervosa. A third type, binge-eating disorder, is pending approval as a formal psychiatric diagnosis. Eating disorders frequently develop during adolescence or early adulthood, and they occur more often in females than in males. Studies have shown cognitive behavioral therapy (CBT) to be the most effective approach to treating eating disorders. However, the applicability of these findings to clinical settings and intensive outpatient therapy programs (IOPs) remains unknown. This study will evaluate the effectiveness of a new approach to a normalization of eating (NOE) program, based on principles of CBT, in treating women with anorexia nervosa or bulimia nervosa.

Participants in this open-label study will be assigned to receive either treatment-as-usual (TAU) or NOE. Participants admitted to the study in the first 8 months of the trial will receive TAU. Those admitted after the first 8 months will take part in the NOE program. Participants may begin receiving treatment as soon as they enter the study and will continue receiving their assigned treatments for 6 weeks. All participants in the NOE group will be required to report to the study site three evenings a week. They will receive individual therapy, as well as take part in group and family therapy sessions. In addition, they will be supervised while eating a meal. Body weight, results of the Eating Disorders Examination and the Structured Clinical Interview for DSM-IV Axis I disorders, and self-report measures will be assessed post-treatment and at the Month 6 follow-up visit.

Note: Participants are recruited from the Renfrew Center's outpatient programs located in the Philadelphia area. Individuals outside of Renfrew cannot volunteer for this study. For more information about the Renfrew Center's inpatient or outpatient treatment programs, please call 1-800-RENFREW.

Study Phase
Study Type  Interventional
Study Design  Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Primary Outcome Measure  Body weight [ Time Frame: Measured at baseline, discharge, and 6 month follow-up ] [ Designated as safety issue: No ]
Structured Clinical Interview [ Time Frame: Measured at baseline ] [ Designated as safety issue: No ]
Self-report [ Time Frame: Measured at baseline, discharge, and 6 month follow-up ] [ Designated as safety issue: No ]
Eating Disorders Examination [ Time Frame: Measured at baseline, discharge, and 6 month follow-up ] [ Designated as safety issue: No ]
Secondary Outcome Measure 
Condition  Eating Disorders
Intervention  Behavioral: Normalization of Eating (NOE)
Behavioral: Treatment As Usual (TAU)
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  280
Start Date  January 2006
Completion Date
Eligibility Criteria 

Inclusion Criteria:

  • Diagnosis of an eating disorder or eating disorder not otherwise specified (except for binge eating disorder), as defined by the Diagnostic and Statistical Manual of the American Psychiatric Association
  • Agrees to remain in IOP treatment for at least 3 weeks
  • Seeking treatment in one of the Renfrew Center's outpatient programs located in the Philadelphia area

Exclusion Criteria:

  • Diagnosis of eating disorder not otherwise specified, including binge eating disorder
  • Diagnosis of a psychotic disorder
  • Transferred to inpatient treatment during the IOP stay because of worsening health
Gender Female
Ages 15 Years to 40 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Michael R. Lowe, PhD     215-762-1190     lowe@drexel.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00272545
Organization ID R34 MH71691
Secondary IDs †† DATR A2-AIR
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Michael R. Lowe, PhD     Drexel University    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date February 2008
First Received Date  January 4, 2006
Last Updated Date February 28, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers